Vaccines against aids comprising CMV/ R-nucleic acid constructs

Details for Australian Patent Application No. 2005274948 (hide)

Owner The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services GenVec, Inc.

Inventors Chakrabarti, Bimal; King, C. Richter; Yang, Zhi-Yong; Huang, Yue; Xu, Ling; Wu, Lan; Nabel, Gary J.; Gall, Jason G. D.

Agent FB Rice

Pub. Number AU-B-2005274948

PCT Pub. Number WO2006/020071

Priority PCT/ US2004/030284 15.09.04 US; 60/588,378 16.07.04 US; PCT/ US2005/012291 12.04.05 US

Filing date 15 July 2005

Wipo publication date 23 February 2006

Acceptance publication date 22 September 2011

International Classifications

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/020071 Priority application(s): WO2006/020071

22 September 2011 Application Accepted

  Published as AU-B-2005274948

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274949-Payment card signal characterization methods and circuits

2005274938-A method for refinery foulant deposit characterization